225 related articles for article (PubMed ID: 31929191)
1. Preclinical evaluation of patient-derived cells shows promise for Parkinson's disease.
Takahashi J
J Clin Invest; 2020 Feb; 130(2):601-603. PubMed ID: 31929191
[TBL] [Abstract][Full Text] [Related]
2. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O
Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606
[TBL] [Abstract][Full Text] [Related]
3. Induced dopaminergic neurons: A new promise for Parkinson's disease.
Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
[TBL] [Abstract][Full Text] [Related]
4. Combining physical & cognitive training with iPSC-derived dopaminergic neuron transplantation promotes graft integration & better functional outcome in parkinsonian marmosets.
Daadi EW; Daadi ES; Oh T; Li M; Kim J; Daadi MM
Exp Neurol; 2024 Apr; 374():114694. PubMed ID: 38272159
[TBL] [Abstract][Full Text] [Related]
5. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.
Zheng X; Han D; Liu W; Wang X; Pan N; Wang Y; Chen Z
Theranostics; 2023; 13(8):2673-2692. PubMed ID: 37215566
[No Abstract] [Full Text] [Related]
6. Engraftable Induced Pluripotent Stem Cell-Derived Neural Precursors for Brain Repair.
Zygogianni O; Kouroupi G; Taoufik E; Matsas R
Methods Mol Biol; 2020; 2155():23-39. PubMed ID: 32474865
[TBL] [Abstract][Full Text] [Related]
7. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
Chen W; Huang Q; Ma S; Li M
ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
[TBL] [Abstract][Full Text] [Related]
8. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
Fan Y; Winanto ; Ng SY
Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
[TBL] [Abstract][Full Text] [Related]
9. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
[TBL] [Abstract][Full Text] [Related]
10. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.
Hallett PJ; Deleidi M; Astradsson A; Smith GA; Cooper O; Osborn TM; Sundberg M; Moore MA; Perez-Torres E; Brownell AL; Schumacher JM; Spealman RD; Isacson O
Cell Stem Cell; 2015 Mar; 16(3):269-74. PubMed ID: 25732245
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains.
Kikuchi T; Morizane A; Doi D; Okita K; Nakagawa M; Yamakado H; Inoue H; Takahashi R; Takahashi J
J Neurosci Res; 2017 Sep; 95(9):1829-1837. PubMed ID: 28233934
[TBL] [Abstract][Full Text] [Related]
12. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy.
Yeap YJ; Teddy TJW; Lee MJ; Goh M; Lim KL
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768843
[TBL] [Abstract][Full Text] [Related]
13. Stem Cell Therapy for Parkinson's Disease.
Han F; Hu B
Adv Exp Med Biol; 2020; 1266():21-38. PubMed ID: 33105493
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization, and banking of clinical-grade cells for neural transplantation: Scale up, fingerprinting, and genomic stability of stem cell lines.
Natalwala A; Kunath T
Prog Brain Res; 2017; 230():133-150. PubMed ID: 28552226
[TBL] [Abstract][Full Text] [Related]
15. Redefining Parkinson's disease research using induced pluripotent stem cells.
Pu J; Jiang H; Zhang B; Feng J
Curr Neurol Neurosci Rep; 2012 Aug; 12(4):392-8. PubMed ID: 22622410
[TBL] [Abstract][Full Text] [Related]
16. Effect of Cell Adhesion Molecules on the Neurite Outgrowth of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons.
Peng SP; Schachner M; Boddeke E; Copray S
Cell Reprogram; 2016 Apr; 18(2):55-66. PubMed ID: 26990843
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges.
Xiao B; Ng HH; Takahashi R; Tan EK
J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):697-702. PubMed ID: 26833176
[TBL] [Abstract][Full Text] [Related]
18. Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease.
Zhang L; Yang H
Mol Biol Rep; 2024 Feb; 51(1):347. PubMed ID: 38400887
[TBL] [Abstract][Full Text] [Related]
19. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.
Xu X; Huang J; Li J; Liu L; Han C; Shen Y; Zhang G; Jiang H; Lin Z; Xiong N; Wang T
Cell Prolif; 2016 Feb; 49(1):14-26. PubMed ID: 26748765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
